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ABBREVIATIONS
AR Antibiotic resistance or resistant
ARG Antibiotic resistance gene
CP Coupling protein
CNV Copy-number variation
epicPCR Emulsion, paired isolation and concatenation PCR
HGT Horizontal gene transfer
INDEL Insertion or deletion
ICE Integrative and conjugative element
MGE Mobile genetic element
MBC Minimum bactericidal concentration
MIC Minimum inhibitory concentration
MMR Methyl-directed mismatch repair system
Mpf Mating pair formation







Competition between lineages with differ-
ent adaptive mutations, interfering with the 
strength and directionality of selection. Clonal 
interference is caused by the inability of adap-
tive mutations to recombine into the same ge-
nome in asexually reproducing organisms, such 
as bacteria.
Conjugation
Transfer of DNA from donor to recipient cell 
through a type IV secretion system comprising 
a mating pair formation (Mpf ) complex and the 
coupling protein (CP). Mpf components (pro-
tein complex and pilus) establish physical con-
tact with a recipient cell and create a secretion 
pore. The CP delivers the DNA to pore entry 
and potentially partakes in secretion.
Ecological interactions
Important ecological interactions include com-
petition, predation and parasitism. The major 
predators of bacteria are protozoa, which are 
unicellular eukaryotes, and the major parasites 
are bacteriophages, which are viruses that in-
fect bacteria.
Emulsion, paired isolation and concaten-
tion PCR (epicPCR)
A culture-independent method for detection 
of the presence of two DNA regions in the same 
cell in a heterogeneous sample. Individual cells 
are trapped in polyacrylamide beads. Linker 
primer PCR is used to amplify two DNA regions 
into a fusion product. After nested PCR, the 
fragment is sequenced. When one region is a 
phylogenetic marker, epicPCR allows detection 
of the phylogenetic distribution of a gene of in-
terest.
Epistasis
The fitness effect of a locus is altered by the 
presence of another locus. In positive and neg-
ative epistasis, two mutations in combination 
produce higher or lower fitness, respectively, 
than the sum of counterparts. In sign epistasis, 
the sign of a mutation (fitness-beneficial/-neg-
ative) changes.
Evolutionary forces
Drift, natural selection, mutation, recombina-
VII
tion and gene f low. Mutation, recombination 
and gene flow create genetic (allelic) variabil-
ity in a population of an organism. In bacteria, 
recombination and gene flow mainly occur 
through horizontal gene transfer. Drift and se-
lection act on the variability, determining the 
change in allele frequency over time. Drift de-
notes random change in allele frequency, and 
its effect is inversely proportional to population 
size. Selection denotes non-random change 
in allele frequency. Selection can be positive, 
where the frequency of an adaptive allele in-
creases over time, or negative (i.e. purifying), 
where the frequency of a maladaptive allele de-
creases.
Horizontal gene transfer (HGT)
Transfer of DNA between cells, which can 
represent the same or different species. HGT 
mechanisms include conjugation, transduction 
(HGT via bacteriophages), transformation (di-
rect uptake of environmental DNA), and trans-
fer via membrane vesicles.
Methyl-directed mismatch repair system 
(MMR)
A post-replicative DNA error correction mecha-
nism. The proteins MutS, MutH and MutL coor-
dinate binding to and excision of the daughter 
strand at the site of a DNA mismatch, followed 
by repair by DNA Polymerase III.
Minimum inhibitory concentration (MIC)
The minimum antibiotic concentration inhib-
iting visible growth of a bacterial population in 
vitro under a specified cultivation protocol.
Minimum selective concentration (MSC)
The antibiotic concentration where antibiotic 
resistant and susceptible genotypes have equal 
fitness, and drift and natural selection equally 
determine the fate of antibiotic resistance. At 
concentrations exceeding the MSC, which is 
usually lower than the MIC, the antibiotic resis-
tant genotype can be subject to positive selec-
tion.
Mobile genetic element (MGE)
Genetic element that shows mobility within or 
between genetic elements or cells. MGEs in-
clude plasmids, integrative and conjugative el-
ements, bacteriophages, transposable elements 
and integrons. Environmental DNA can also be 
considered an MGE.
Negative frequency dependent selection
The fitness of a species or genotype increases 
with decreasing frequency, which can be caused 
e.g. by cross-feeding interactions, parasitism 
and predation. This is an example of balancing 
selection maintaining species coexistence.
Niche differentiation
Resource use or spatial separation of members 
in a community, reducing competitive interac-
tions and enabling coexistence.
Plasmid
An independently replicating extrachromo-
somal, usually circular DNA molecule. Often 
encodes beneficial traits, such as antibiotic re-
sistance, and conjugative machinery allowing 
horizontal transfer between cells.
Pleiotropy
A gene influences more than one phenotypic 
trait.
Protozoa
An informal term used to refer to unicellular eu-
karyotes that feed on organic matter, which can 
include bacteria (bacterivory).
Single-nucleotide polymorphism (SNP)
A point mutation in a bacterial genome com-
pared to ancestral reference genome, including 
single-base substitutions, insertions and dele-
tions.
SOS response
The presence of single-stranded DNA in a cell 
indicative of cellular damage leads to a global 
change in gene regulation, including recruit-
ment of low-fidelity DNA polymerases. This 
allows replication over damaged DNA and in-
creases mutation rate.
Species diversity
The number (richness) and similarity in abun-
dance (evenness) of species in a community, 




Antibiotics often occur in different environments 
at concentrations insufficient to inhibit the growth 
of susceptible bacteria. Subinhibitory concentra-
tions can, nevertheless, select for chromosomal 
antibiotic resistance mutations and mobile genetic 
elements carrying antibiotic resistance genes, such 
as conjugative plasmids. However, it has been un-
clear whether this occurs in typical natural habitats 
where bacteria live in multispecies communities 
and interact with viral and protozoan consumers. 
In such settings, similar selection can also occur on 
other bacterial traits, potentially interfering with 
antibiotic resistance evolution.
In this thesis, the combined effect of low an-
tibiotic concentrations and ecological interactions 
on antibiotic resistance evolution was investigat-
ed. The thesis consists of four studies. In the first 
and second study, antibiotic and bacteriophage re-
sistance evolution was examined at the phenotypic 
or whole-genome level when a bacterial population 
was exposed to one versus both factors. In the third 
study, the effect of antibiotics and protozoan pre-
dation on the spread and maintenance of a conju-
gative antibiotic resistance plasmid in a bacterial 
population was determined. The fourth study ex-
amined the effect of a low antibiotic concentration, 
protozoan predation, and spatial layout of habitat 
on community composition and horizontal trans-
fer of a conjugative plasmid in a multispecies bac-
terial community.
Antibiotic resistance evolution was shown 
to be promoted by low antibiotic concentrations 
independent of the presence of ecological inter-
actions. The presence of protozoan predation also 
promoted the spread and maintenance of a resis-
tance plasmid even in the absence of antibiotics. 
This demonstrates that ecological factors other 
than antibiotics can also play a role in the horizontal 
transfer of antibiotic resistance genes. Moreover, a 
low antibiotic concentration altered bacterial com-
munity composition, diversity, and the strains that 
received a resistance plasmid, although predation 
and spatial layout of habitat were equally strong 
or stronger drivers. Since the community effects 
of low antibiotic concentrations can be weaker or 
similar in strength to the effects of other ecological 
drivers, knowledge of antibiotic alone may be in-
sufficient for predicting changes in the structure or 
diversity of a community.
IX
TIIVISTELMÄ
Antibiootteja esiintyy eri ympäristöissä usein niin 
alhaisina pitoisuuksina, etteivät ne estä edes niille 
herkkien bakteerien kasvua. Tällaisetkin pitoisuudet 
voivat kuitenkin tuottaa valintapainetta, jolloin an-
tibiooteille vastustuskykyä aiheuttavat kromosom-
aaliset mutaatiot tai liikkuvat geneettiset elementit, 
kuten konjugatiiviset plasmidit, lisääntyvät bakteeri-
populaatiossa. Vielä ei tiedetä, päteekö tämä baktee-
rien tyypillisissä elinympäristöissä, joissa bakteerit 
ovat osa monilajisia yhteisöjä ja vuorovaikutuksessa 
virusten sekä alkueläinsaalistajien kanssa. Tällaisissa 
olosuhteissa valintapaine voi kohdistua myös muihin 
bakteerin ominaisuuksiin, mikä voi häiritä antibioot-
tiresistenssievoluutiota.
Tässä työssä tutkittiin alhaisten antibioot-
tipitoisuuksien ja ekologisten vuorovaikutusten 
yhteisvaikutusta antibioottiresistenssievoluutioon. 
Työ koostuu neljästä osatutkimuksesta. Ensimmäi-
sessä ja toisessa osatutkimuksessa tarkasteltiin an-
tibiootti- ja virusresistenssin evoluutiota bakteerin 
ilmiasussa tai perimässä altistamalla bakteeri joko 
antibiootille tai virukselle tai molemmille. Kolman-
nessa osatutkimuksessa tarkasteltiin antibiootin 
ja alkueläinsaalistuksen vaikutusta konjugatiivisen 
antibioottiresistenssiplasmidin leviämiseen ja säi-
lymiseen bakteeripopulaatiossa. Neljännessä osa-
tutkimuksessa tarkasteltiin alhaisen antibioottip-
itoisuuden, alkueläinsaalistuksen ja avaruudellisen 
rakenteen vaikutusta yhteisörakenteeseen sekä 
konjugatiivisen plasmidin leviämiseen monilajisessa 
bakteeriyhteisössä.
Tutkimuksessa havaittiin, että alhaiset anti-
bioottipitoisuudet lisäsivät antibioottiresistenssiä 
bakteeripopulaatiossa myös ekologisten vuorovai-
kutusten alaisuudessa. Lisäksi alkueläinsaalistus 
edisti resistenssiplasmidin leviämistä ja säilymistä 
bakteeripopulaatiossa antibiootista riippumatta. 
Tämä osoittaa, että myös muut ekologiset tekijät 
kuin antibiootit voivat olla merkityksellisiä antibio-
ottiresistenssigeenien liikkuvuuden kannalta. Moni-
lajisessa bakteeriyhteisössä matala antibioottipitoi-
suus muutti yhteisön rakennetta, monimuotoisuutta 
ja plasmidin vastaanottavia kantoja. Myös alkueläin-
saalistus ja avaruudellinen rakenne muuttivat näitä 
tekijöitä vähintään yhtä voimakkaasti. Koska matalan 
antibioottipitoisuuden vaikutus yhteisöön voi olla 
samaa suuruusluokkaa tai pienempi kuin keskeisten 
ekologisten tekijöiden, tieto pelkästään antibiootista 
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1
A ntibiotics are substances which, at sufficient concentrations, kill bacteria (bactericidal an-
tibiotics) or prevent their reproduction (bacterio-
static antibiotics). They function by impairing key 
cellular functions such as replication, transcrip-
tion, translation or cell wall synthesis. Fungi and 
bacteria synthesizing antibiotics are ubiquitous 
in nature. Phylogenetic studies suggest antibiotic 
synthesizing genes to have emerged over 2 billion 
years ago.1,2 The ecological function of antibiot-
ics has been hypothesized to be the inhibition of 
competitors.3 For instance, fungi have longer gen-
eration times than bacteria, which gives bacteria 
a competitive advantage in nutrient uptake. Anti-
biotic production may therefore be a competitive 
strategy utilized by fungi to secure nutrients for 
their use. Alternatively, antibiotics have been sug-
gested to function as signaling molecules owing 
to the belief that environmental concentrations 
(in the low ng l–1 or kg–1 when detectable)4-6 are too 
low to exert inhibitory effects7,8. However, antibi-
otic concentrations in pristine environments are 
poorly understood due to precision and accuracy 
problems of detection methods4,5 and likely uneven 
concentration distributions. Therefore, the preva-
lence of inhibitory concentrations in natural envi-
ronments remains unclear.
1 INTRODUCTION
1.1 Antibiotics  and their
occurrence at subinhibitory 
concentrations
2
The discovery of antibiotics started in the early 20th century with ar-
sphenamine (1907: Paul Ehrlich) that was synthesized chemically9 and penicillin 
(1928: Alexander Fleming) that was produced by the fungus Penicillium chrysoge-
num10. In 1940–1960, many of the major classes of modern antibiotics were discov-
ered, and, facilitated by the development of large-scale industrial manufacture, 
they revolutionized the ability of humans to treat infectious diseases that had pre-
viously been the leading cause of death (Table 1).11 Today, in addition to production 
by naturally occurring microbes, many antibiotics can be synthesized chemically 
or by genetically engineered microbes.
In 1950–1960, antibiotics were widely adopted in veterinary medicine for 
the treatment of bacterial infections, and in animal agriculture also for growth 
promotion and the control of endemic diseases.12 More antibiotics are currently 
used in agriculture and aquaculture than in human healthcare.13,14 Global antibiotic 
use in animal agriculture alone is estimated to have exceeded 63,000 tons in 2010 
and to rise by 67% by 2030.15 β-lactams are the most widely used class of antibiot-
ics, especially in animal agriculture, having recently been reported to account for 
over half of total global antibiotic sales.16,17 The total use of antibiotics, the use of 
different antibiotic classes, and measures taken to control antibiotic use in human 
and animal healthcare and agriculture display strong geographic and geopolitical 
patterns. Antibiotic use is highest and least controlled in certain low- and mid-
dle-income countries, especially countries in Asia.15,18,19
To assess antibiotic susceptibility and dosing in human healthcare, the con-
cept of minimum inhibitory concentration (MIC) was developed. MIC is defined 
as the minimum antibiotic concentration that inhibits visible growth of a bacterial 
population in vitro under a specified cultivation protocol. An extension of MIC, the 
minimum bactericidal concentration (MBC) denotes a concentration that causes 
a reduction of ≥ 99.9 % of bacteria in an inoculum. MBC is usually the same as MIC 
for bactericidal antibiotics, and several-fold higher than the MIC for bacteriostatic 
antibiotics.20 Effective dosing of antibiotics, most frequently administered orally or 
intravenously, requires that serum concentrations exceed the MIC for a sufficient 
proportion of the dosing time interval. MIC is expressed as µg ml–1. In other words, 
concentrations in the range 1–1000 mg l–1 are typically required for complete inhi-
bition of the growth of susceptible bacteria. Following the dosing time interval, an-
tibiotics occur at decreasing sub-MICs in tissues until complete elimination. The 
time it takes for an antibiotic to be eliminated depends on its half-life. For instance, 
the half-life of vancomycin is 6–12 h, such that it takes over two days to eliminate 
99 % of the antibiotic.20
Depending on the antibiotic class, 20–80 % of ingested antibiotics are ex-
creted by humans and animals, mainly in urine and feces.21 The excreted antibiotics 
subsequently end up in wastewater, sludge and manure. Although less widespread, 
significant industrial antibiotic pollution also occurs from production plants.22 As 
a consequence, antibiotic concentrations in human-impacted environments, such 
as agricultural and aquaculture settings and the water bodies and soils receiving 
wastewater treatment plant and antibiotic production plant effluents, can exceed 
those found in pristine environments by several orders of magnitude. In the most 
polluted sites23-25, concentrations can exceed 10 mg l–1 and 100 mg kg–1, and be in the 
µg l–1 to mg l–1 order in surrounding water bodies and soils. However, lower con-
centrations are reported in more commonplace scenarios. For instance, concen-
trations in the 1–10 µg l–1 range can occur in municipal wastewater26, although the 





































ronments, rarely exceeding 1 µg l–1 27. Concentrations reported in different envi-
ronments are summarized in Table 2. Different environments where antibiotics 
occur are depicted in Figure 1.
In summary, in a large range of environments, antibiotics occur at sub-
MICs, including a substantial proportion of total antibiotic exposure time for 
the tissues of humans and animals receiving antibiotic therapy. Moreover, high 
concentrations are typically associated with spatial and temporal concentration 
gradients ranging from super-MICs to sub-MICs. It is therefore of interest to un-
derstand whether sub-MICs affect bacteria, and in what way.
Global antibiotic resistance problem
G enes whose products confer bacteria resistance to antibiotics are ancient, diverse and prevalent in nature, particularly in soil, paralleling the evolu-
tion and ecology of antibiotic synthesis genes.1,2,28,29 However, in recent decades, 
the prevalence of antibiotic resistant (AR) bacteria and genes (ARGs) has in-
creased in human and animal healthcare, as well as in certain human-impacted 
environments. Furthermore, positive correlations have been frequently found 
between this trend and levels of human antibiotic use.30-36 Although bacterial 
strains infecting humans and animals usually differ37, as do human, animal, and 
environmental bacterial communities, there are also indications of AR strains 
and ARGs spreading at the human-animal-environment interface35,38,39. This rais-
es concerns about the potential role of environmental antibiotic residuals in the 
occurrence and enrichment of AR human and animal pathogens.40
The successive emergence of antibiotic resistance in clinically relevant 
bacteria, often within just a few years after the introduction of an antibiotic to the 
market, has gradually produced a global medical crisis: certain forms of resistance 
are prevalent, with resistance being detected against most of the antibiotics avail-
able.41,42 This includes last-resort antibiotics prescribed only after the failure of 
conventional therapies.43 Emerging antibiotic resistance decreases the efficacy of 
first-line antibiotic therapies prescribed prior to susceptibility testing, resulting 
in prolonged duration of disease and increased incidence of sequelae and death. 
Although the occurrence of clinically relevant AR strains mirrors geographic pat-
terns in antibiotic consumption, strains and their resistance determinants spread 
through travelers and foodstuff across the globe.44
The antibiotic resistance crisis is exacerbated by the lack of financial in-
centives for pharmaceutical companies to invest in new antibiotic discovery for 
reasons including high competition and low expected profits compared to drugs 
for chronic illnesses.45 The demand for low manufacturing costs can also feed 
back into the antibiotic resistance problem by driving generic antibiotic produc-
tion to countries where plant emissions tend to be high, such as India.46
The antibiotic resistance crisis comes at a time in human history when 
globally increased lifespans, the ability to treat serious medical conditions and 
accessibility to medical treatment have resulted in an increased number of im-
munocompromised people.47,48 As their body’s ability to fight infections is weak-












AMOUNT PER L/KG ENVIRONMENT
Water body or soil around typical 
source of emissions
Water body or soil around a highly 
polluted source
Highly polluted source of emissions
Tissues of human or animal receiving 
antibiotic therapy
*Complete inhibition of the growth of 
susceptible bacteria is possible
Pristine environment
ened, they rely on antibiotics and can receive large 
numbers of antibiotic prescriptions, promoting 
the emergence of multidrug resistant strains. Im-
munocompromised people are also susceptible to 
infections by environmental and commensal bac-
teria (so called opportunistic pathogens), which 
stresses the medical importance of measures to 
detect and avoid enrichment of AR bacteria in hu-
man habitats or the environment. To illustrate the 
scale of the problem, currently in the United States 
and Europe there occur annually millions of AR in-
fections, of which approximately 50,000 result in 
death.49,50 This represents, for example, double the 
annual number of fatalities from road accidents in 
the European Union.51 A strong increase in AR fatal-
ities is predicted in the following decades, although 
reliable quantitative estimates are lacking.52
Mechanistic ba sis of antibiotic resistance
Antibiotic resistance can be an intrinsic property of 
a bacterial cell, such as absence of the antibiotic tar-
get, impermeability of cell membrane, or the pres-
ence of chromosomal genes whose products inacti-
vate or degrade the antibiotic or pump it out from the 
cell (i.e. efflux pumps).53 Alternatively, an AR mu-
tation can emerge in a bacterial population (adap-
tive resistance) or a susceptible cell can become 
resistant through horizontal gene transfer (HGT; 
acquired resistance).54 The antibiotic resistance 
crisis is primarily brought about by the enrichment 
of adaptive or acquired resistance to previously ef-
fective antibiotics in bacteria whose intrinsic resis-
tance determinants have already been established 
and first-line therapies designed accordingly. In the 
case of opportunistic infections, in particular, lack 
of information concerning intrinsic resistance can
FIGURE 1 | Different environments where antibiotics occur. These include antibiotic production plant ef-
fluents, patient tissues in the healthcare setting, water bodies receiving wastewater, agricultural and aqua-
culture settings, and sites where naturally occurring microbes produce antibiotics.
Original illustration courtesy of Johanna Muurinen, re-rendered by No Jam Studio.
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Emergence and f itness ef fects of antibiotic
 resistance mutations
Mutation supply rate, i.e. the number of mutations 
produced over one generation, is the product of 
effective population size and mutation rate. Mu-
tation supply over a fixed time interval is therefore 
inversely proportional to generation time. Bacteria 
can have large population sizes and short genera-
tion times, and therefore high mutational poten-
tial, relative to eukaryotes. Bacterial mutation rate 
is primarily determined by replication error rate, 
defined by the fidelity of DNA polymerase, a typical 
mutation rate being 1/300 mutations per genome 
per replication.60 Furthermore, both genetic and 
inducible factors can increase mutation rate by up 
to several orders of magnitude. For instance, muta-
tor strains with high mutation rates can be caused 
by mutations in genes encoding components of 
the mismatch repair (MMR) system that performs 
post-replicative error correction.61 Moreover, the 
presence of single-stranded DNA in a bacterial cell 
due to cellular damage induces the SOS response, 
causing recruitment of low-fidelity DNA poly-
merases to continue replication, thereby increas-
ing the mutation rate.62
Most mutations are point mutations (i.e. 
single nucleotide polymorphisms, SNPs), includ-
ing single-base substitutions, insertions and dele-
tions. Together the latter two are referred to as IN-
DELs, which can also be longer. INDELs that alter 
the reading frame of a gene are called frameshift 
mutations. In addition to replication errors, var-
1. 2.1 ADAPTIVE RESISTANCE
ious mechanisms can cause structural variations 
in bacterial chromosomes, which also contribute 
to bacterial mutation supply. These include large 
insertions, deletions, inversions, translocations 
(i.e. relocation of a chromosomal segment) and du-
plications. Among these, duplications (often adja-
cent, i.e. tandem) or deletions and inversions result 
from homologous recombination between repeat-
ed sequence elements and inverse-order repeated 
sequence elements, respectively.63
Non-synonymous (amino acid altering) 
point mutations and frameshift mutations in the 
coding sequence of a gene are likely to affect the 
fitness of a bacterium. Recently, synonymous (ami-
no acid preserving) mutations in coding sequences 
have also been shown to affect fitness due to codon 
usage preferences in genomes (e.g. codon com-
position biased to host tRNA pool).64,65 Structural 
variations can also affect fitness through a number 
of mechanisms. For instance, gene duplications in-
crease the amount of the gene product, potentially 
altering the functioning of the cell. Most mutations 
that have a fitness effect are deleterious66, since al-
terations in the amino acid sequence of a protein 
can produce a misfolded, improperly functioning 
or non-functional protein. More generally, the like-
lihood of a random mutation to improve a cellular 
structure or function is lower than the likelihood 
of impairment. Notably, a subset of deleterious 
mutations is lethal, and the mutation supply rate is 
therefore higher than the number of surviving mu-
tations that can be experimentally detected.
Random mutations that produce AR pheno-
also account for the failure of first-line antibiotic therapies.55
The increase in antibiotic resistance is essentially an evolutionary phenomenon, resulting from 
natural selection and drift acting on genetic variability produced by mutation, recombination and gene 
flow (comprising the five classical evolutionary forces). In bacterial populations, gene flow and recombi-
nation especially occur through HGT. HGT is estimated to account for up to 25–33 % of the genes in bac-
terial genomes56,57, where they belong to the variable accessory genome as opposed to the conserved core 
genome58. Bacterial AR phenotypes caused by both mutations and HGT are observed frequently, although 
the precise relative contribution of each is unclear.59 The ecology and evolution of AR mutations and HGT 
are discussed separately below, with special regard to the potential role of sub-MICs.
TABLE 3. Examples of point mutations causing antibiotic resistance.
*Mutations are a prevalent form of resistance 
observed against the antibiotic class
Ribosomal component (rpsL, rrs)72
Penicillin-binding protein 5 (pbp5)73
Cell wall synthesis regulator (vraSR, graSR)74
DNA-topoisomerase (gyrAB, parCE)* 75,76














types are likely to have adverse fitness effects in the absence of antibiotics.67 One 
reason for this is that mutations generally have a negative effect on fitness. Fur-
thermore, since antibiotics usually target key cellular functions, resistance muta-
tions might have stronger negative effects than random mutations have on aver-
age. This phenomenon is referred to as the fitness cost of resistance. Fitness costs 
of adaptive mutations represent antagonistic pleiotropy whereby a beneficial mu-
tation is coupled with a negative effect on another trait. Although common, not all 
AR mutations carry fitness costs. Empirical findings range from > 50 % to little or 
no fitness cost.68 The variability in fitness costs can result from the different phys-
iological effects and genetic and ecological backgrounds of resistance mutations. 
Although unlikely, certain AR mutations might even have synergistic pleiotropic 
(i.e. fitness-beneficial) effects on other traits, which can result in increased fitness 
in the absence of antibiotic.69
SNPs conferring resistance to different antibiotic classes readily evolve in 
laboratory experiments and are an important reason for AR infections in the clin-
ical context. SNPs displaying resistance to several antibiotics (synergistic pleiot-
ropy) of the same or even different classes can also occur due to the antibiotics 
affecting the same cellular function or component.70  Examples of SNPs causing 
antibiotic resistance are shown in Table 3. Among other frequently occurring mu-
tation types, duplications of genes encoding antibiotic efflux pumps produce phe-
notypes with higher levels of antibiotic resistance.71
Antibiotic concentration required for selection of resistance
Antibiotic concentration can affect antibiotic resistance evolution in two ways. It 
can affect the fate of the same mutation occurring in the same genetic background, 
and it can affect the type of mutation selected. The fate of the same mutation is 
affected by its associated fitness cost and interference interactions within the ge-
nome, population and community. For selection to occur, the antibiotic concen-
tration must first exceed the minimum selective concentration (MSC), denoting 
fitness neutrality compared to susceptible cells (Figure 2A).79 At the MSC, drift and 
selection act equally on the mutation, and a rare AR mutation is likely to be lost 
through drift. One study reports MSCs to different antibiotics ranging between 
1/4 and 1/230 × MIC.79 In another study examining 111 antibiotics and 11 antibiotic 
combinations, upper boundaries for MSCs were estimated to range between 69 µg 
and 32 mg l–1 and concentrations below 8 ng to 64 µg l–1 to cause no selection for 
resistance (see Table 2 for concentrations occurring in different environments).80 
Therefore, both the MSC and its relation to MIC vary by several orders of magni-
tude among different antibiotics.
In asexually reproducing organisms like bacteria, adaptive mutations 
cannot be purged from background mutations, including deleterious mutations, 
through recombination.81 For an adaptive mutation to be selected in a linked ge-
nome, its selection coefficient (fitness benefit) must exceed a characteristic 
threshold representing the typical level of interference (Figure 2B).82 The antibiot-
ic concentration where selection for resistance is likely to occur therefore exceeds 
the MSC by a certain threshold. Starting from this concentration, the strength of 
selection increases with increasing concentrations. In the extreme case, only one 
clonal lineage can survive in the concentration. In this scenario, the mutation and 
all the background mutations (hitchhikers) become fixed in the population even 
10
when the genetic background includes deleterious mutations. This is called a se-
lective sweep (Figure 2C).
Moreover, in asexually reproducing organisms, adaptive mutations fre-
quently occur in different lineages in the population. Again, because of linked 
genomes, adaptive mutations in separate lineages cannot recombine to the 
same genome, causing competition between lineages (Figures 2B and 2D).81,83,84 
Such clonal interference decreases the strength and directionality of selection. 
Therefore, even with a positive combined fitness effect of the mutations in a 
genome including an AR mutation, at the lower selective concentration range, 
other equally adaptive genotypes are likely to emerge in other lineages, causing 
interference on AR selection. For a selective sweep of an AR mutation to occur 
in a bacterial population, the antibiotic concentration, and thereby, the fitness 
benefit of the resistance mutation must surpass this interference effect.
In addition to clonal interference, ecological mechanisms maintaining 
species coexistence can also interfere with directional selection at the commu-
nity-level (Figures 2E and 2F). These include niche partitioning through spatial 
or resource use separation, and balancing selection mechanisms. For instance, 
cross-feeding interactions are common between bacteria. Here, one bacterium 
is a superior competitor for an exogenous resource and another bacterium uses 
a byproduct of this member. This creates negative frequency dependent selec-
tion where bacterial fitness increases with decreasing frequency, allowing stable 
coexistence of the bacteria.85 For competitive dominance of an AR genotype, the 
fitness benefit of the AR mutation might need to surpass also the forces main-
taining stable coexistence of species in a community.
Instead of only one particular mutation conferring antibiotic resistance 
to a particular antibiotic, there is usually a whole range of AR mutations that have 
different fitness costs in the absence of antibiotic and that confer different lev-
els of resistance. These range from high-level resistance mutations specifically 
targeting the antibiotic to low-level resistance mutations affecting aspects such 
as stress tolerance, and from common point mutations to rare mutational com-
binations and structural variations. Intermittent antibiotic exposure can also se-
lect for tolerance mutations, such as mutations increasing the lag phase of cells, 
allowing short-term survival under antibiotic exposure.87
Antibiotic concentration can affect both the size of the mutational space 
and which mutations in the space are selected. The lower the concentration is 
in the selective range, the more genetic variability can be maintained, increasing 
the supply of adaptive mutations both in space and over time. A higher supply 
of mutations increases the chance of the occurrence of rare AR mutations or 
mutational combinations that are either fitness-neutral or even -beneficial in 
the absence of antibiotics.88 Since the fitness effect of an AR mutation is deter-
mined by the benefit provided minus the cost in the absence of antibiotic, the 
lower the concentration, the lower the cost and the more fitness-beneficial the 
genetic background must be for a mutation to be selected.88 Furthermore, since 
by definition the MIC completely inhibits the growth of susceptible cells, only 
rare high-level resistance mutations will be selected at super-MICs. High-level 
resistance mutations are more likely to be physiologically coupled with higher 
fitness costs due to having a stronger effect on the cellular function targeted by 
the antibiotic.69 Together these factors result in enhanced selection for low-cost 
AR mutations at sub-MICs compared to super-MICs. Such low-cost resistance 
































































































































FIGURE 2 | Population genetic and ecological mechanisms affecting antibiotic resistance mutational tra-
jectories. (A, on previous page) Any concentration above the minimum selective concentration (MSC) 
where the growth rate of a resistance mutant (red line; “res”) exceeds the growth rate of a susceptible cell 
(blue line; “susc”) can select for antibiotic resistance. This includes concentrations both above and below 
the minimum inhibitory concentration (MIC) that completely inhibits the growth of a susceptible cell. 
Modified from Gullberg et al. 2011.79 (B, on previous page) In a non-recombining population of N individ-
uals with two-nucleotide genomes of length L, evolution is affected by positive and negative interference 
interactions between beneficial (green), neutral (blue) and deleterious mutations (red). Here, alleles 2 
and 3 may drive hitchhiking allele 1 to fixation, and compete with allele 4, which may either drive allele 5 to 
fixation or be driven to loss by it. Modified from Schiffels et al. 2011.82 (C–F) Periodic selective sweeps (C, 
E) and clonal interference (D, F) at the population (upper panels) and community level (lower panels; two 
species/genotypes are separated by a dashed line). Modified from Marx 2013.86 The color codes in A, B and 
C–F are unrelated.
Original illustration courtesy of Matti Ruuskanen, re-rendered by No Jam Studio.
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owing to these same factors, is specifically en-
hanced by exposure to a gradient of increasing anti-
biotic concentrations.
Adaptation frequently involves more than 
one mutation, and mutations often interact, a 
phenomenon known as epistasis.89 Positive and 
negative epistasis denote a situation where two 
mutations in combination produce higher or lower 
fitness, respectively, than the sum of the counter-
parts. Sign epistasis denotes a situation where the 
sign of a mutation (fitness-beneficial or -negative) 
changes depending on the presence of another mu-
tation. Epistatic interactions have been shown to 
be altered by antibiotic concentration, such that 
the mutational combinations producing optimal 
fitness differ.90 Thus, different mutational com-
binations are selected at different antibiotic con-
centrations. Furthermore, the largest amount of 
antibiotic resistance evolutionary potential (mu-
tational combinations) is produced by exposure of 
a bacterial population to a range of concentrations 
rather than a single antibiotic concentration.
Concerns have been raised about the po-
tential threat imposed by sub-MICs that can se-
lect for low-cost, and occasionally high-level, AR 
mutations.79,88 However, compared to super-MICs, 
these concentrations also produce weaker selec-
tion because of smaller selection coefficients and 
increased interference interactions. Furthermore, 
AR mutants selected at super-MICs also frequent-
ly evolve to grow similar to susceptible cells in the 
absence of antibiotics through accruing second-
ary-site beneficial mutations that compensate for 
the fitness cost of resistance.91 Overall, the amount 
of quantitative data on key parameters is current-
ly insufficient for accurate predictions concerning 
AR mutational trajectories at different concentra-
tions.92 The modes in which decreasing antibiotic 
concentrations are likely to alter the evolution of 
antibiotic resistance are summarized in Table 4.
Horizontal gene transfer and mobile genetic el-
ements
Genes conferring AR phenotypes can be acquired 
without host mutations horizontally from other 
bacterial cells representing the same or a closely re-
lated species, or even disparate bacterial taxa. HGT 
occurs through four mechanisms: transformation, 
membrane vesicles, transduction and conjugation. 
Natural transformation is the direct uptake of en-
vironmental DNA by bacteria. The DNA is typically 
bound to a type IV pilus, transported to the cyto-
plasm and integrated into the host chromosome 
via homologous recombination or reassembled as 
an independently replicating molecule. Function-
al ARGs can be transferred through transforma-
tion.93,94 Antibiotics that disturb cell wall synthesis 
might also improve the transformation competen-
cy of cells, increasing HGT via transformation.94 
However, functional gene transfer via transforma-
tion might be uncommon, in part, because of the 
requirement for sequence homology with host for 
recombination to occur. Transfer of DNA, includ-
ing ARGs, can also occur between two cells via 
membrane vesicles95,96, although the prevalence of 
this HGT mechanism is unclear.
Transduction refers to HGT mediated by 
viruses that infect bacteria (bacteriophages, or 
simply, phages). In transduction, packaging of spe-
cific or nonspecific parts of the host chromosomal 
DNA into phage particles, defined as specialized or 
generalized transduction, respectively, is followed 
by integration of the DNA into the genome of an 
infected host through homologous recombination. 
Transduction has been shown to transfer ARGs, 
and the abundance of ARGs in environmental vi-
romes suggests that the role of transduction in ARG 
transfer might be unappreciated.97,98 In addition to 
HGT through transduction, phages that integrate 
as prophages to the host genome (i.e. temperate 
phages) can also alter host phenotype as well as 
encode superinfection immunity against co-infec-
tion of the cell by another phage. In superinfection 
immunity, the resident prophage expresses repres-
sor proteins that block the genome functioning of 
1. 2.1 ACQUIRED RESISTANCE
TABLE 4. Effect of decreasing antibiotic
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a secondary (superinfecting) phage whose genome has successfully entered the 
cell. This might inhibit HGT through transduction, although mobilization of 
functional ARGs to the host cell from a transducing phage despite inability of the 
phage to replicate due to superinfection immunity has been shown.99 Antibiotics 
might also increase transduction by inducing prophages (excision from chromo-
some and initiation of lytic cycle), allowing the phages and the ARGs they carry 
to infect and integrate to the genomes of other bacterial lineages.100
Conjugation is the transfer of DNA from donor to recipient cell (both in-
ter- and intra-specifically) via cell-to-cell contact established by a type IV pilus. 
The DNA transferred is usually an independently replicating extrachromosomal 
molecule, a plasmid, which frequently encodes beneficial accessory traits. Ac-
quisition of plasmid-located ARGs, which can confer resistance to all major an-
tibiotic classes, represents a highly prevalent mechanism causing antibiotic re-
sistance in bacterial pathogens in the clinical context (Table 5).101 These include 
genes encoding extended-spectrum-lactamases102 and vancomycin resistance103 
in the critical and high priority pathogens in the World Health Organization pri-
ority pathogens list.104 Plasmids are also the most important source of multidrug 
resistance due to either co-occurring ARGs or point mutations increasing ARG 
activity range.105,106 There is high variation in plasmid copy number, stability, and 
gene content, with sizes ranging from less than 1 kb to more than 1 Mb. Moreover, 
plasmids can also be non-conjugative, although some among them (small mul-
ticopy plasmids) are horizontally mobilizable by the presence of a conjugative 
plasmid in the same host bacterium.107 In addition to conjugative plasmids, in-
tegrative and conjugative elements (ICEs) are mobile genetic elements (MGEs) 
integrated to the host genome which encode a functional conjugation system 
and can transfer between cells.108,109
Integrons and transposable elements, which include transposons and 
insertion sequences, are also important MGEs. However, with the exception of 
conjugative transposons, which belong to ICEs, they lack HGT mechanisms of 
their own. DNA transposons are sequences that can change their location with-
in or between DNA molecules through a cut-and-paste mechanism catalyzed by 
transposase enzymes, and they generally carry accessory genes. Insertion se-
quences are small transposable elements that only encode proteins required for 
transposition. A composite transposon is a transposon flanked by insertion se-
quences that is mobilized as a complete unit. Integrons are promoter-containing 
assembly platforms that collect genes into a series of gene cassettes, by site-spe-
cific recombination mediated by an integrase enzyme, and ensure their expres-
sion.118 These gene cassettes frequently contain ARGs.119 The MGEs participate 
in HGT interactively: gene cassettes collected by integrons can be incorporated 
into transposons.118 The transposons can subsequently be mobilized between 
host chromosomes by plasmid intermediates.120,121 The process has resulted in 
highly mosaic MGE structures. Clusters of genes in bacterial genomes acquired 
by HGT are called genomic islands, which in the clinical context frequently en-
code virulence and AR traits.122
Conjugative pla smid dynamics
Among the MGEs, conjugative plasmids play a disproportionately important 












Aminoglycoside-modifying enzymes (aac, ant, aph)*110
β-lactamases hydrolyzing β-lactams (bla)*111
Prevention of binding to cell wall precursors (van)*112, 113




Examples of antibiotic resistance gene groups located on plasmids.
* Plasmids are a prevalent source of resistance observed against the antibiotic class
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they carry but also non-conjugative plasmids123, 
transposable elements120, integrons118 and nonspe-
cific host DNA elements124. Factors governing the 
transfer and selection of conjugative plasmids are 
therefore important determinants of antibiotic re-
sistance.
Plasmid conjugation is a biomolecular reac-
tion in which a donor cell transfers a plasmid to a 
recipient cell (transconjugant). The potential for 
and likelihood of plasmid transfer is affected by a 
variety of factors. First, to maintain the plasmid, 
the recipient cell must be within the host range of 
the plasmid, and must not contain another, incom-
patible plasmid. The host range of a plasmid can be 
narrow or broad. Narrow host range plasmids can 
transfer only among closely related species. Broad-
est host range plasmids exhibit transfer across 
diverse gram-negative bacteria.125 Inter-gram plas-
mid transfer has also been documented, especially 
from gram-positive to gram-negative bacteria126-128, 
as well as conjugative plasmid transfer from bacte-
ria to microbial eukaryotes129.
The host range of a plasmid is determined 
by its physical ability to transfer to another cell 
and, more importantly, by its replication system 
and interaction with host factors.130 The type IV 
secretion system involved in the physical transfer 
of a plasmid comprises a mating pair formation 
(Mpf ) complex and the coupling protein (CP). 
Plasmid-encoded Mpf components (protein com-
plex and pilus) establish physical contact between 
the donor and recipient cell and create a secretion 
pore, and the CP delivers the DNA to the entry of 
the secretion pore, potentially also participating 
in active secretion of DNA.131 The replication of a 
successfully transferred plasmid requires the es-
tablishment of the replisome through DNA-protein 
and protein-protein interactions. A failure to repli-
cate can be caused, for example, by deficient inter-
action between the plasmid origin of replication 
(ori) or replication initiation protein (Rep) with 
host proteins, deficient regulation of expression of 
essential plasmid genes, or instability or mislocal-
ization of plasmid encoded proteins in the bacterial 
cell.
Alongside transfer to an out-of-host-range 
bacterium, stable maintenance of a plasmid is also 
prevented if the cell contains a plasmid with the 
same origin of replication. When the origin of rep-
lication is the same, competition for replication 
factors leads to rapid loss of one of the plasmids.132 
Based on sharing the same replication strategy, 
plasmids are categorized into incompatibility 
groups whose members are unable to coexist in 
the same cell. Moreover, plasmid stability is influ-
enced by the presence and type of mechanism for 
segregating plasmid copies from parent to progeny 
cells encoded in partitioning (par) loci.133 Plasmid 
incompatibility can also arise when two plasmids 
share the same partition mechanism. Here, incom-
patibility is usually thought to result from random 
plasmid type allocation to progeny cells, leading 
to gradual loss of one of the plasmids.133,134 Plas-
mid-host compatibility might also be affected, al-
though not completely prevented, by other factors 
such as differences between codon usage prefer-
ences.135
The likelihood of plasmid transfer to a suit-
able recipient is defined by several factors, includ-
ing donor-recipient encounter rate and conjuga-
tion efficiency. Donor-recipient encounter rate 
is determined both by population sizes and the 
physical layout of the habitat. For instance, on the 
one hand, structured environments (e.g. biofilms) 
provide increased cell-to-cell contact and stability 
of Mpf compared to well-mixed aqueous environ-
ments.136 On the other hand, spatial structuring can 
cause physical isolation of subpopulations, which 
might prevent plasmid spread between subpopu-
lations.
Conjugation efficiency is affected by both 
donor and recipient cell physiology. Conjugation 
requires the expression of the conjugation machin-
ery by the donor. This depends on the growth phase: 
300-fold higher conjugation efficiencies have been 
observed for donor cells in the exponential growth 
phase compared to the stationary growth phase.137 
A smaller effect is also caused by the growth phase 
of the recipient, such that (approx. eightfold) de-
creased conjugation efficiencies are observed with 
recipients in the exponential compared to the 
stationary growth phase. This could be caused by 
improved donor recognition of the recipient due 
















FIGURE 3 | Conjugative plasmid dynamics under antibiotic selection. Mobilization of an antibiotic re-
sistance plasmid through conjugation from donor (green) to suitable recipient cell (red), resulting in 
transconjugants (blue), and increase in transconjugant prevalence are separate processes that can be dif-
ferentially affected by antibiotic selection. (A) The emergence and prevalence of transconjugants in the 
absence of positive selection is determined by donor and recipient encounter rate, conjugation efficiency, 
segregation error rate and transconjugant fitness. (B) If an antibiotic causes expression of the conjuga-
tive machinery, this may increase conjugation efficiency and transconjugant prevalence. (C) Abundance 
changes caused by increased donor or reduced recipient fitness under antibiotic selection can, however, 
promote clonal expansion of the donor at the expense of conjugative transfer. (D) Antibiotics can select 
for transconjugants if their fitness surpasses parental strain fitness. Notably, the outcome is similar to B 
but the mechanism is different. Adapted from Lopatkin et al. 2016.137
Original illustration courtesy of Matti Ruuskanen, re-rendered by No Jam Studio.
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Role of antibiotic selection in conjugative pla smid dynamics
Current evidence on the effect of sub-MICs of antibiotics on plasmid con-
jugation efficiency is unclear (Figure 3). While sub-MICs have been shown 
to increase ICE conjugation efficiency by either activating the excision of 
genes from the chromosome or by inducing the conjugation machinery138,139, 
evidence for plasmids is lacking and potential enhancement is limited to cas-
es where the conjugation machinery is not constitutively expressed (Figure 
3B).137 More speculatively, sub-MICs might indirectly increase conjugation 
efficiency through causing global cellular responses. However, sub-MICs can 
also decrease plasmid conjugation frequency by reducing donor or recipient 
population size and thereby the encounter rate, or by causing clonal expan-
sion of the donor (Figure 3C).
Once a transconjugant emerges in a population, its selection by an 
antibiotic requires that it possesses higher fitness than the donor strain har-
boring the same plasmid and its parental strain lacking the fitness cost caused 
by plasmid carriage (Figure 3D). Positive selection for the plasmid causes an 
increase in transconjugant frequency when these conditions are met, but oth-
erwise promotes clonal expansion of the donor at the expense of transcon-
jugants (Figure 3C).121,137 Interestingly, sub-MICs granting the transconjugant 
higher fitness than either parental strain are likely to decrease conjugation 
frequency by reducing parent encounter rate. Therefore, the conditions un-
der which sub-MICs promote ARG mobility might be narrow.
Compared to transconjugant selection, positive selection has a clearer 
role in the selection for lineages already containing plasmids. Similar to AR 
mutations, plasmid transfer and carriage are typically associated with fitness 
costs in the host cell in the absence of positive selection.140 Fitness costs of 
plasmids can be caused by a multitude of factors, the most important likely be-
ing the biosynthetic burden from expressing plasmid-encoded genes.140 With 
a sufficient fitness cost of plasmid carriage or segregation error rate resulting 
in plasmid-free progeny cells, the plasmid is likely to be lost from the popula-
tion in the absence of sufficient positive selection or conjugation efficiency. 
Notably, conjugation efficiency alone can be sufficient to maintain a plasmid 
in a population.141 Plasmid selection and plasmid transfer are not necessarily 
mutually exclusive processes, since plasmid selection increases donor prev-
alence, and thereby, encounters between the donor and potential recipients.
Dif ferences between conjugative pla smids and adaptive mutations
Similar to adaptive mutations, the strength of AR plasmid selection is ex-
pected to increase with increasing super-MSCs of antibiotics. However, the 
segregation error rate and conjugation efficiency of a conjugative plasmid 
can have a considerable impact on plasmid dynamics. In the extreme case, as 
mentioned above, positive selection is not required at all but plasmid conju-
gation efficiency alone is sufficient to maintain a plasmid in a population. In 
contrast, for adaptive mutations to increase to a high frequency, a certain du-
ration of positive selection is required unless selection strength is sufficient 
to completely prevent the reproduction of individuals lacking the mutation. 
If an AR plasmid cannot be stably maintained in the absence of positive se-
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lection due to fitness costs or segregation error, it 
will be lost from the population through negative 
(i.e. purifying) selection or by chance, respective-
ly, despite having swept through the population. 
However, for adaptive mutations that have fixed in 
the population, reversal to the ancestral state and, 
thereafter, loss from the population requires highly 
unlikely reverse mutations that restore the ances-
tral genotype. Furthermore, due to frequently en-
coding multiple accessory traits, a wider spectrum 
of conditions might create positive selection for AR 
plasmids compared to AR mutations. For instance, 
in addition to other antibiotics, environmental 
concentrations of heavy metals or detergents re-
sulting from human activity can co-select for ARGs 
due to co-localization on the same plasmid as heavy 
metal or detergence resistance genes142,143.
Similar to adaptive AR mutations, compen-
satory mutations can remove the fitness effect of 
plasmid carriage on the host cell in the absence of 
positive selection.144-147 However, unlike AR muta-
tions, in addition to the host chromosome, com-
pensatory mutations to plasmid carriage can also 
occur in the plasmid with a higher gene copy num-
ber and, therefore, mutation rate compared to the 
host. Also, with plasmids, compensatory mutations 
can target aspects related to host compatibility, 
such as different codon usage preferences.148 The 
evolution of decreased fitness costs, along with 
evolution of increased conjugation efficiencies, 
might explain the widespread occurrence of plas-
mids in natural bacterial communities irrespective 
of the presence of positive selection.149
Compared to AR mutations, AR plasmids 
are also subject to unique ecological phenome-
na. For instance, source-sink dynamics whereby 
a plasmid is transiently maintained in unsuitable 
hosts due to constant conjugative transfer from 
an abundant donor can enable wide access to plas-
mid-encoded ARGs in bacterial communities.150 
Furthermore, a special feature of certain chromo-
somal or plasmid-located ARGs encoding antibi-
otic-inactivating enzymes is the capacity to confer 
resistance to surrounding cells.151 This enables, un-
der the same level of selection, a higher proportion 
of plasmid-free cells in the population compared 
to ARGs conferring resistance only for the host 
cell. Conjugative plasmid carriage can also com-
promise the cell, since there are phages that infect 
hosts through plasmid-encoded pili.152,153 All these 
phenomena affect the change in prevalence, trans-
fer and particular selective pressures faced by, and 
therefore the fate of, plasmids and plasmid-encod-
ed ARGs. Differences between antibiotic resistance 
caused by mutations or conjugative plasmids are 
summarized in Table 6.
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Feature Adaptive mutation Conjugative plasmid
TABLE 6.






































































1.3 ANTIBIOTICS AND RESISTANCE IN MICROBIAL
COMMUNITIES
Impor tance of communit y conte x t for how anti-
biotics af fect bacteria
O ver the course of approximately 3.9 billion years154, evolutionary forces have produced 
tremendous biodiversity on Earth. Most of the 
species diversity is accounted for by microbes, in-
cluding bacteria, archaea, viruses and unicellular 
eukaryotes.155,156 The most abundant entities are 
phages, the viruses of bacteria, which account for 
most of the 1031 viruses on Earth, followed by 1030 
bacteria and archaea.157 Among the most abundant 
unicellular eukaryotes, bacterivorous protozoa oc-
cur at high densities in soil (e.g. 1.5 × 104 amoebae 
g–1) and aquatic environments (e.g. 102–106 hetero-
trophic flagellates ml–1).158 Bacteria159, phages160, and 
protozoa161 are also all abundant in the mammalian 
gut. Importantly, these organisms interact at a high 
rate, forming multispecies, multitrophic microbial 
communities. Because of their major role in bacte-
rial ecology and evolution, the fate of AR mutations 
and HGT of ARGs are likely to be affected by the 
species interactions occurring in realistic commu-
nity setting (Figure 4).162
In multispecies bacterial communities, 
niche differentiation and balancing selection can 
limit the strength and directionality of selection for 
AR mutations compared to a single species setting 
(see section 1.2.1 Adaptive resistance and Figures 
2C–F).164,165 Overall, ecology can also be critical for 
the species involved in HGT163,164, although precise 
tracking of conjugative ARG plasmid transfer in 
multispecies settings has been hindered by meth-
odological challenges165,166. Therefore, controlled 
testing of predictions concerning the effect of dif-
ferent antibiotic concentrations and other ecolog-
ical factors on ARG plasmid transfer in complex 
communities is currently lacking. Furthermore, 
in multispecies settings, the effects of antibiotics 
can go beyond selection for AR mutations or pro-
motion or inhibition of HGT of ARGs. The effect 
of antibiotics is determined by the resistance (in-
sensitivity to disturbance) and resilience (rate of 
recovery after disturbance) of the community to 
disturbances.167,168 A sufficiently strong disturbance 
may result in a regime shift, denoting a persistent 
change in the structure or function of a commu-
nity.169,170 Altered community composition and 
functioning can, in turn, impair ecosystems171 and 
health158,159. While high antibiotic concentrations 
cause strong changes in community composition 
and reduce diversity by driving susceptible spe-
cies and genotypes to extinction, sub-MICs too 
can cause decreased diversity over the long term 
through increasing fitness variance172,173. Howev-
er, the extent of the effect of sub-MICs relative to 
other key ecological factors, such as habitat struc-
turing and trophic interactions, has received little 
attention prior to this thesis.174
Ef fect of trophic interactions on antibiotic re-
sistance evolution
Prevalent trophic interactions with phage and pro-
tozoan consumers can also affect the ecology and 
evolution of antibiotic resistance. Consumers reg-
ulate bacterial population size and create strong 
selection for phage resistance175 and anti-predatory 
defense176 due to the death of susceptible cells. An-
tibiotic and phage resistance usually have different 
cellular mechanisms, evolving independently177. 
Under this scenario, the likelihood for a co-resis-
tant double mutant to be present in a bacterial 
population upon exposure to both agents at lethal 
doses is very low (product of individual mutation 
probabilities). Therefore, a drastic crash occurs in 
the bacterial population, which might even go ex-
tinct.178 The bacterial population crash and associ-
ated prevention of antibiotic resistance evolution 
make phage-antibiotic combination therapies a 
promising alternative to single antibiotic, antibi-
otic combination (where resistances display more 
positive associations), and phage therapies in the 
medical context.177,179 
Compared to high concentrations, the eco-
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FIGURE 4 | Antibiotic resistance evolution occurs in communities of multiple bacterial species (green cir-
cles) that interact at a high rate with phage and protozoan consumers (red circle). Here, horizontal transfer 
of an antibiotic resistance plasmid (dark green) between two bacterial species is shown. Competitive in-
teractions between species and trophic interactions with consumers (black lines) might affect the trajec-
tories of antibiotic resistance mutations or horizontal transfer of resistance genes. This can occur through 
altered species abundance, cell physiology, or selective landscape. HGT = horizontal gene transfer.
Original illustration courtesy of Teppo Hiltunen, re-rendered by No Jam Studio.
Predation / parasitism
HGT
logical and evolutionary dynamics of bacterial pop-
ulations co-exposed to phages and sub-MICs are 
less well understood.180 In this scenario, a weaker 
reduction in population size, primarily caused by 
the phage, is followed by recovery of a high popu-
lation size. The bacterial population, now display-
ing high-frequency resistance to the phage, has 
recovered high mutation supply, enabling AR mu-
tations to readily evolve against a phage resistant 
background. The combined fitness cost of phage 
and antibiotic resistance might, however, cause the 
requirement for stronger positive selection (i.e. 
higher antibiotic concentration) for co-resistant 
mutants to be selected, although this requirement 
might be removed by compensatory adaptations.
Current evidence suggests that phages lim-
it conjugative plasmid mediated antibiotic resis-
tance. In addition to decreased conjugation fre-
quency as a result of population size reductions 
caused by phages, the combined cost of chromo-
somal phage resistance mutations and AR plasmid 
carriage can cause the requirement for stronger 
positive selection for plasmid maintenance.181 
Furthermore, phages that infect the host through 
adsorbing to plasmid encoded pili select for conju-
gation-defective mutant plasmids, restricting the 
conjugative transfer of AR plasmids.152 
Compared to phages, the effect of protozo-
an predation on antibiotic resistance evolution has 
received little attention. However, although proto-
zoa lack the therapeutic relevance of phages, their 
potential effect on AR mutations or plasmid trans-
fer is non-trivial. In aquatic environments, which 
constitute > 90 % of the biosphere, protozoan pre-
dation is often prevalent and can determine bacte-
rial properties (Figure 5).182
Similar to phages, decreased bacterial popu-
lation size and selection for anti-predatory defense 
mutations can decrease the rate of antibiotic resis-
tance evolution under predation. This effect can be 
stronger for protozoa, which constantly regulate 
bacterial abundance compared to intermittent ly-
sis by phages. In contrast, protozoa cause weaker 
selection for anti-predatory defense, since grazing 
removes a smaller fraction of susceptible bacteria. 
Compared to phages and antibiotics which have 
specific genomic targets of resistance mutations, 
protozoa might also select for mutations affecting 
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more general traits such as cell aggregation (for different defense types, see 182), 
decreasing effective prey population size or increasing prey handling time.183 
Therefore, the mutations or mutational combinations causing increased levels 
of anti-predatory defense might be more numerous but possess smaller selec-
tion coefficients. Compared to phages, these factors can increase the likelihood 
of co-resistance and antibiotic resistance evolution under predation at su-
per-MICs, while decreasing antibiotic resistance evolution through increasing 
the relative effect of interference interactions at sub-MICs. Protozoan abun-
dances are also more even than phage abundances, and can maintain frequency 
dependent selection for defended and undefended prey genotypes. Under such 
a dynamic selective regime, AR genotypes might confer a lower fitness benefit at 
sub-MICs184, requiring higher concentrations for AR selection. Since cell aggre-
gation causes both increased anti-predatory defense and increased antibiotic re-
sistance183,185, pleiotropic mutations causing co-resistance might also be possible.
Protozoa can have variable effects on conjugative AR plasmid dynamics. 
Predation can inhibit plasmid transfer by reducing bacterial population size.186 
Furthermore, the combined fitness cost of anti-predatory defense and plasmid 
carriage might decrease plasmid maintenance. Alternatively, predation might 
increase the frequency of plasmid conjugation by maintaining bacteria in an ac-
tive growth state. The maintenance of bacteria under predation at a more active 
growth state has been demonstrated empirically187 and through modeling188. Ow-
ing to the importance of an active growth state to the expression of the conjuga-
tion machinery, a link between predation and increased conjugation activity was 
recently independently hypothesized by us (III) and another research group166.
27
FIGURE 5 | Gram-negative bacteria (purple) predated by the ciliated protozoan Tetrahyme-
na thermophila (green; proportions approx. 20 × 50 µm).
Helium ion micrograph by Matti Jalasvuori.
M y doctoral thesis investigated the interplay between sub-MICs of antibiotics, antibiotic 
resistance (via either mutations or horizontal gene 
transfer), and species interactions.
The specific aims of the thesis were:
• To study the effect of a virulent bacte-
riophage parasite and two sub-MICs 
of streptomycin on the evolution of a 
bacterial population using phenotypic 
assays (I) and whole-genome sequenc-
ing (II)
• To study the effect of a protozoan 
predator and sub-MIC of kanamycin 
on the spread and maintenance of a 
conjugative multidrug resistance plas-
mid in a bacterial population (III)
• To study the effect of a protozoan 
predator, sub-MIC of kanamycin and 
spatial structuring on community 
composition and the spread of a multi-
drug resistance plasmid in a multispe-
cies bacterial community (IV)
2 AIMS OF THE THESIS
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T he methods and strains used in each study are explained in detail in the articles (I–IV) and their supplementary materials. A summary of the methods is presented in Table 7.
3 SUMMARY OF MATERIAL AND METHODS
TABLE 7.







and CNVs in WGS data
Sanger sequence






































4.1 ADAPTIVE MUTATIONS 
UNDER SPECIES 
INTERACTIONS (I, II)
I n a bacterial population exposed to 0.01 or 0.1 × MIC streptomycin over a 66-day evolutionary 
experiment, we found that AR phenotypes readi-
ly evolved in 0.1 × MIC streptomycin (4/6 popula-
tions) irrespective of the presence of a phage (I). 
Streptomycin resistance was likely explained by 
mutations in the rpsL gene encoding the small sub-
unit ribosomal RNA protein S12 previously shown 
to cause streptomycin resistance in bacteria (II; 
Figure 6).189 Furthermore, in 3/4 rpsL mutated pop-
ulations, the mutations were fixed or near-fixed by 
the experimental end-point, suggesting that they 
confer strong fitness benefits unaffected by the 
evolutionary history of phage adaptation.
AR mutations were observed in 2/3 replicate 
populations in both univariate and co-selected en-
vironments, while the experiment lacked power to 
detect potential sub-MIC effects that occur only 
in a subset of populations. Therefore, to further 
investigate the potential role of 0.1 × MIC strepto-
mycin on antibiotic resistance evolution, we con-
ducted a 12-day experiment with four biological 
replicates (different bacterial colonies), each com-
prising 48 technical replicates (I). Here, we found 





presence of the phage compared to streptomycin 
alone. However, the genetic determinants account-
ing for these observations are unknown. 
Similarly, contrary to predictions of de-
creased rates of adaptation in multivariate com-
pared to univariate environments, in the 66-day 
experiment, we found higher levels of phage resis-
tance phenotypes (I) and likely associated muta-
tions (II) in bacteria under co-selection (Figure 6). 
Interestingly, this occurred despite a population 
size reduction in the presence of the phage and the 
antibiotic, predicted to further decrease adapta-
tion through decreasing mutation supply. This out-
come is even less expected since phage extinction 
should remove selection for phage resistance. The 
phage became extinct in the sub-MIC treatments 
by day 14/66 and 40/66 under 0.01 × MIC and 0.1 × 
MIC streptomycin, respectively, while remaining 
at a detectable level throughout the experiment 
in the absence of streptomycin. We also ruled out 
that these observations are caused by pleiotropic 
effects of antibiotic or phage resistance, as isolates 
from univariate environments with resistance phe-
notypes were not co-resistant (I: Supplementary 
materials), and the genetic resistance determi-
nants were the same for co-selective and univari-
ate environments (II; Figure 6). In line with these 
observations, the genomic data showed lack of 
clonal interference between antibiotic and phage 
resistance alleles, as they co-occurred in the same 
genomes under co-selection.
Together these results call into question the 
generality of decreased strength and directionality 
of selection under multiple selection pressures, 
which, however, was observed in the same system 
for bacteria and ciliates.184 Beyond pleiotropy, one 
proposed mechanism compensating for decreased 
strength of selection in multivariate environments 
is selection by one or several variables for mutators, 
i.e. strains with increased mutation rates caused, 
for example, by mutations in MMR genes.190,191. 
WGS analysis of the 66-day experiment end-point 
showed the presence of MMR mutants at high fre-
quency in several populations, including 4/6 of the 
co-selected populations, and lack of MMR mutants 
in the presence of phage alone (II; Figure 6). How-
ever, phage resistance mutations occurred at high 
frequency in the co-selection treatment also in the 
two populations lacking mutator alleles, and mu-
tator alleles also occurred in the absence of either 
phage or streptomycin. This suggests that random 
distribution of mutator alleles across the experi-
mental populations is unlikely to explain the obser-
vation of increased phage resistance under co-se-
lection by chance, and that this is either in part or 
completely explained by other factors.
Sub-MICs of antibiotics can also be muta-
genic, transiently increasing bacterial mutation 
rate, and thereby, potentially increasing the rate 
of adaptation to phages. In line with this, we found 
that sub-MICs of streptomycin increased the rate 
of bacterial mutation to phage resistance, although 
the effect was relatively weak (I). The effect of dif-
ferent antibiotics at sub-MICs on the rate of bac-
terial mutation to phage resistance was recently 
tested more extensively, with some similar, sta-
tistically significant results, although the effects 
were generally weak and inconsistent across dif-
ferent phages.178 Furthermore, in our experiment, 
the death of non-mutants in the fluctuation assay 
caused by streptomycin could have inflated mutant 
frequency, although this is unlikely, since the high-
est mutation rate was observed for the least inhibi-
tory concentration (0.01 × MIC). New sophisticat-
ed approaches (implemented e.g. in the R package 
rSalvador192) have recently been developed for the 
determination of mutation rates, incorporating a 
larger number of potential sources of error.
The lack of clear associations between in-
creased rates of adaptation under co-selection and 
either pleiotropy or inducible or evolved hypermu-
tability suggests that there exist other population 
genetic or ecological mechanisms that can account 
for these observations. These include positive epis-
tasis between phage and streptomycin resistance 
mutations193 and altered bacteria-phage co-evolu-
tionary dynamics under streptomycin.175,194,195 Fur-
thermore, while the population crash caused by 
a phage and lethal antibiotic concentrations178,196 
necessitates the presence of rare co-resistant mu-
tants for population survival, sub-MICs do not 
pose an immediate requirement for AR genotypes. 
Once the bacterial population recovers from phage 
exposure, containing a high prevalence of phage 
resistance genotypes, AR mutations are likely to 
emerge, and the sooner this occurs, the more like-
ly AR mutations are to emerge against a phage re-
sistant background. This might increase the likeli-
hood for co-resistance evolution under sub-MICs. 
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FIGURE 6 | Parallel evolution in experimental populations of Pseudomonas f luorescens SBW25 evolved for 
66 days in the absence (top) or presence (bottom) of the phage SBW25Φ2 and absence or presence of one 
of two sub-MICs of streptomycin. 0.2 and 2 µg ml–1 represent 0.01 and 0.1 × MIC, respectively. Mutations 
are indicated by dots, with the size of the dot representing the proportion of mutated genotypes in each 
population (min. 10%, max. 100%).  Each concentric circle represents mutations along the chromosome 
in an individual bacterial population.. The phage appears to select for mutations in LPS biosynthesis genes 
(LPS is a known target of the phage), which, however, occur almost exclusively in the presence of strepto-
mycin.
Reproduced from II with permission by John Wiley & Sons, Inc, re-rendered by No Jam Studio.
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variance between genotypes172,173, sub-MICs of antibiotics might promote extinction of phage suscepti-
ble genotypes or increase the selection coefficient for AR mutations appearing in a costly phage resistant 
background, also increasing rates of resistance and co-resistance evolution. However, such dynamics can-
not be reconstructed from our experimental end-point and warrant further investigation (for discussion 
of selection inference from single time point sequence data, see 197).
4.2 PLASMID TRANSFER UNDER
SPECIES INTERACTIONS (III, IV)
Exposure of a bacterial population harboring a multidrug resistance plasmid to 0.1 × MIC 
kanamycin resulted in a decreased rate of kana-
mycin-resistance encoding RP4 plasmid loss over 
60 days (III: Figure 7). This demonstrates that the 
sub-MIC used compensated for the fitness cost of 
plasmid carriage although not sufficiently to allow 
for plasmid maintenance in the long term. Notably, 
a conjugative version of the plasmid was lost more 
readily than its conjugation-defective counter-
part. This suggests that active conjugation exerts 
a larger fitness cost to the host cell compared to 
plasmid maintenance alone, and therefore requires 
stronger positive selection for the plasmid to be 
maintained in the bacterial population. Interest-
ingly, this scenario was reversed under predation 
by a ciliated protozoan: The conjugation-defec-
tive plasmid was lost while the conjugative plas-
mid was maintained at close to 100 % prevalence. 
Importantly, this was unaffected by the presence 
of positive selection. Therefore, the ecological ef-
fect of protozoan predation alone was sufficient 
to maintain the plasmid in the population through 
promotion of conjugative transfer, counteracting 
negative selection against the plasmid imposed by 
fitness costs.
We separately demonstrated that the pro-
portion of transconjugants increased under pre-
dation (III: Supplementary materials). We also 
showed that these effects were caused by the pres-
ence of live protozoa rather than compounds re-
leased from the protozoa (III: Supplementary ma-
terials).
Increased conjugation under predation is 
likely explained by maintenance of bacteria in an 
active, non-stationary growth phase,  demonstrat-
ed for protozoan predation187,188 and required for 
expression of the conjugation machinery137,198. This 
effect of predation has been independently hypoth-
esized by another research group166 and, subse-
quent to our study, a similar outcome was reported 
by Bien and colleagues for a different conjugative 
ARG plasmid under grazing by taxonomically and 
physiologically diverse protozoa.199 Higher meta-
bolic activity of bacteria under predation has also 
been demonstrated in the laboratory, supporting 
the mechanistic hypothesis.200 Furthermore, the 
conjugation-promoting effect of ciliates has been 
shown to be strong enough to reverse near-loss of 
the plasmid following exposure to the conjugative 
plasmid dependent bacteriophage PRD1.200 To-
gether these observations demonstrate that proto-
zoa can promote plasmid maintenance in aquatic 
environments under a variety of conditions, al-
though this requires further exploration in natu-
ral systems. An alternative mechanism by which 
predation can facilitate HGT of ARGs is through 
the release of DNA from consumed cells to the 
environment, where it can be acquired by bacteria 
through natural transformation.199,201
We also tested for the effect of protozo-
an predation, structured environment and low 
kanamycin concentration (approx. 6 % of mean 
MIC value of strains) on the transfer of the RP4 
plasmid from one donor strain in a 62-strain arti-
ficial bacterial community over 40 days (IV). The 
structured environment was created by adding 
glass beads to culture vials to allow formation of a 
complex biofilm matrix. Although the method used 
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FIGURE 7 | Prevalence of conjugative and conjugation-defective RP4 plasmid and evolution in prey defense 
trait, D, over time (III; mean ± s.e.). (A-D) The conjugative plasmid in kanamycin-free environment with-
out (A) or with (B) predators, and in 0.1 × MIC kanamycin without (C) or with (D) predators. (E-H) Con-
jugation-defective plasmid in kanamycin-free environment without (E) or with (F) predators, and in 0.1 × 









































FIGURE 8 | The effect of antibiotic on species diversity 
(Shannon’s index) depends on the presence of preda-
tion and spatial structuring (IV).
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plasmid recipients, we detected the presence of plasmid recipients across treatments among over a third 
of the taxa present at the experimental end-point. This shows the capacity of a broad host range plasmid 
to spread through a community under different ecological scenarios.141 Plasmid recipient profiles differed 
between treatments, supporting a key role for ecology in structuring HGT networks.163,164 The number of 
plasmid recipient taxa was higher under sub-MIC antibiotic. This could be caused by the antibiotic favor-
ing taxa more likely to uptake or transfer the plasmid, as the antibiotic treatment was positively associated 
with the MIC value and growth rate of the strain. Alternatively, the antibiotic might have created selection 
for transconjugants.137 The likelihood of receiving the plasmid was coupled strongly with strain abundance, 
but this relationship was weakened in the presence of spatial structures. This could result from increased 
cell-to-cell contact and stability of Mpf in biofilms compared to well-mixed aqueous environments.136
These studies suggest that sub-MICs of antibiotics can promote ARG plasmid maintenance and 
might select for transconjugants in microbial communities. Moreover, key ecological factors, here pro-
tozoan predation and structuring of habitat, are implicated in enhancement of acquired antibiotic resis-
tance. This is hypothesized to be an indirect consequence of altered physiological or physicochemical pa-
rameters affecting plasmid conjugation.
4.3 COMMUNITY COMPOSITION UNDER LOW
CONCENTRATIONS (IV)
In the 40-day experiment with a 62-strain artifi-cial bacterial community, a low kanamycin con-
centration had a strong effect on community com-
position (IV). Furthermore, the antibiotic caused 
reduced diversity in the unstructured environment 
but not in the structured environment (Figure 8). 
These observations support the notion that low 
antibiotic concentrations can reduce the diversity 
of bacterial communities172,173, although this effect 
is less likely to occur in structured environments 
where bacteria can display higher levels of anti-
biotic resistance185. Importantly, the presence of 
other ecological factors (protozoan predation or 
spatial structures), which had strong community 
effects on their own, strongly altered the effect of 
the antibiotic. For instance, predation reversed the 
diversity-decreasing effect of the antibiotic (Figure 
8). This suggests that the community-level effects 
of sub-MICs of antibiotics can be weaker or com-
parable to the effects of other key ecological fac-
tors. This emphasizes the need to incorporate the 
ecological context to predictions concerning the 




I n this thesis, I investigated the effect of low anti-biotic concentrations on adaptive and acquired 
antibiotic resistance in microbial communities. 
Antibiotic resistance was shown to be promoted 
by low antibiotic concentrations or other ecolog-
ical factors in communities, uninhibited by the 
presence of ecological interactions. First, the resis-
tance evolutionary potential of bacteria under low 
antibiotic concentrations was either unaffected 
or enhanced by the presence of phage parasitism. 
Second, protozoan predation maintained a conju-
gative resistance plasmid in a bacterial population 
irrespective of the presence of antibiotic selection. 
Third, the number of bacterial taxa that received 
a resistance plasmid in a multispecies community 
was higher under selection by a low antibiotic con-
centration. Moreover, lower species abundance 
was required for resistance plasmid uptake in a spa-
tially structured environment.
The findings in my thesis show that low 
antibiotic concentrations occurring in human-im-
pacted environments or the healthcare setting can 
promote antibiotic resistance evolution despite 
ecological complexity. Furthermore, they demon-
strate the potential of realistic ecological settings 
to maintain antibiotic resistance genes even in the 
absence of selection. These findings emphasize the 
need for strategies to manage the antibiotic resis-
tance problem that include consideration of low 
concentrations. It is also important to consider the 
possibility that once selected, antibiotic resistance 
5 CONCLUSIONS 
AND PROSPECTS
genes might not easily be lost from microbial com-
munities. This stresses the importance of efforts to 
minimize further resistance evolution, infections 
and infection transmission as means of tackling the 
antibiotic resistance crisis in addition to measures 
taken to reduce the prevalence of current resis-
tance determinants.
The evolution of antibiotic resistance is 
promoted by a range of concentrations, including 
sub-MICs. To better understand the forces shap-
ing antibiotic resistance evolution, continued in-
vestigation into antibiotic resistance trajectories 
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